Cite
Clinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-world study.
MLA
Wei, Yu-Ce, et al. “Clinical Features, Prognostic Stratification, and Treatment of Advanced-Stage Non-Nasal Type Extranodal Natural Killer/T-Cell Lymphoma: A Multi-Institutional Real-World Study.” Annals of Hematology, vol. 103, no. 1, Jan. 2024, pp. 163–74. EBSCOhost, https://doi.org/10.1007/s00277-023-05455-4.
APA
Wei, Y.-C., Liu, W.-X., Qi, F., Zhang, C.-G., Zheng, B.-M., Xie, Y., Chen, B., Zhang, D., Liu, W.-P., Fang, H., Chai, Y., Qi, S.-N., Li, Y.-X., Wang, W.-H., Song, Y.-Q., Zhu, J., & Dong, M. (2024). Clinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-world study. Annals of Hematology, 103(1), 163–174. https://doi.org/10.1007/s00277-023-05455-4
Chicago
Wei, Yu-Ce, Wei-Xin Liu, Fei Qi, Chang-Gong Zhang, Bao-Min Zheng, Yan Xie, Bo Chen, et al. 2024. “Clinical Features, Prognostic Stratification, and Treatment of Advanced-Stage Non-Nasal Type Extranodal Natural Killer/T-Cell Lymphoma: A Multi-Institutional Real-World Study.” Annals of Hematology 103 (1): 163–74. doi:10.1007/s00277-023-05455-4.